| 1. | Which of the following institutes had invited applications for COVID-19 Research Consortium to urgently develop safe and effective Biomedical solutions against SARS CoV-2? |
|||||||
Answer: Option A Explanation: Department of Biotechnology and Biotechnology Industry Research Assistance Council (BIRAC) had invited applications for COVID-19 Research Consortium to urgently develop safe and effective Biomedical solutions against SARS CoV-2. The move aims to provide an accelerator approach for vaccine development. Under the research consortium, DBT and BIRAC evaluated applications with an intent to support Industry/ Academia and Jointly Academia & Industry for developing Diagnostics, Vaccines, Novel Therapeutics, Repurposing of Drugs or any other intervention for control of COVID-19. |
